Bill > HR2404

This bill requires the Comptroller General (the head of the Government Accountability Office) to conduct a comprehensive study on remote monitoring for individuals prescribed opioids and submit a report within 18 months of the Act's enactment. The study must include three key components: first, an assessment of scientific evidence evaluating the effectiveness, individual health outcomes, and potential cost savings of remote monitoring compared to standard prescription practices; second, an analysis of the current prevalence of remote monitoring for opioid patients, including international usage; and third, recommendations for improving the availability, access, and coverage of remote monitoring, potentially through modifications to federal healthcare programs. The report will be submitted to the House Committee on Energy and Commerce and the Senate Committees on Health, Education, Labor, and Pensions and Finance. Additionally, the Comptroller General may identify specific patient groups who could most benefit from remote monitoring when prescribed opioids. Remote monitoring in this context likely refers to technology-enabled tracking and management of patients' opioid use to prevent misuse, addiction, or overdose.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/2404/all-info